Synthesis and evaluation of substituted 4-arylimino-3-hydroxybutanoic acids as potential HIV-1 integrase inhibitors

Synthesis and evaluation of substituted 4-arylimino-3-hydroxybutanoic acids as potential HIV-1... Bioorganic & Medicinal Chemistry Letters 28 (2018) 1067–1070 Contents lists available at ScienceDirect Bioorganic & Medicinal Chemistry Letters journal homepage: www.elsevier.com/locate/bmcl Synthesis and evaluation of substituted 4-arylimino-3-hydroxybutanoic acids as potential HIV-1 integrase inhibitors a c c b,c a,c,⇑ Faridoon , Dumisani Mnkandhla , Michelle Isaacs , Heinrich C. Hoppe , Perry T. Kaye Department of Chemistry, Rhodes University, Grahamstown 6140, South Africa Department of Biochemistry and Microbiolgy, Rhodes University, Grahamstown 6140, South Africa Centre for Chemico- and Biomedicinal Research, Rhodes University, Grahamstown 6140, South Africa article i nfo abstract Article history: A series of readily accessible 4-arylimino-3-hydroxybutanoic acids have been prepared and evaluated as Received 6 November 2017 potential HIV-1 Integrase inhibitors. None of the ligands exhibited significant toxicity against human Revised 29 January 2018 embryonic kidney (HEK 293) cells, while five of them showed activity against HIV-1 integrase – the most Accepted 10 February 2018 active (6c) with an IC value of 3.5 lM. In silico docking studies indicate the capacity of ligand 6c to inter- Available online 12 February 2018 2+ act with several amino acid residues and the two Mg cations in the HIV-1 integrase receptor cavity. 2018 Published by Elsevier Ltd. Keywords: HIV-1 integrase inhibitors http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Bioorganic & Medicinal Chemistry Letters Elsevier

Synthesis and evaluation of substituted 4-arylimino-3-hydroxybutanoic acids as potential HIV-1 integrase inhibitors

Loading next page...
 
/lp/elsevier/synthesis-and-evaluation-of-substituted-4-arylimino-3-hydroxybutanoic-53IOkCAA0c
Publisher
Elsevier
Copyright
Copyright © 2018 Elsevier Ltd
ISSN
0960-894x
D.O.I.
10.1016/j.bmcl.2018.02.020
Publisher site
See Article on Publisher Site

Abstract

Bioorganic & Medicinal Chemistry Letters 28 (2018) 1067–1070 Contents lists available at ScienceDirect Bioorganic & Medicinal Chemistry Letters journal homepage: www.elsevier.com/locate/bmcl Synthesis and evaluation of substituted 4-arylimino-3-hydroxybutanoic acids as potential HIV-1 integrase inhibitors a c c b,c a,c,⇑ Faridoon , Dumisani Mnkandhla , Michelle Isaacs , Heinrich C. Hoppe , Perry T. Kaye Department of Chemistry, Rhodes University, Grahamstown 6140, South Africa Department of Biochemistry and Microbiolgy, Rhodes University, Grahamstown 6140, South Africa Centre for Chemico- and Biomedicinal Research, Rhodes University, Grahamstown 6140, South Africa article i nfo abstract Article history: A series of readily accessible 4-arylimino-3-hydroxybutanoic acids have been prepared and evaluated as Received 6 November 2017 potential HIV-1 Integrase inhibitors. None of the ligands exhibited significant toxicity against human Revised 29 January 2018 embryonic kidney (HEK 293) cells, while five of them showed activity against HIV-1 integrase – the most Accepted 10 February 2018 active (6c) with an IC value of 3.5 lM. In silico docking studies indicate the capacity of ligand 6c to inter- Available online 12 February 2018 2+ act with several amino acid residues and the two Mg cations in the HIV-1 integrase receptor cavity. 2018 Published by Elsevier Ltd. Keywords: HIV-1 integrase inhibitors

Journal

Bioorganic & Medicinal Chemistry LettersElsevier

Published: Apr 1, 2018

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial